India Globalization Capital Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IGC | ZTS | TAK | GRFS | NBIX |
| Company | India Globalization Capital Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.4210 | 152.63 | 13.08 | 6.36 | 137.47 |
| High | 0.4960 | 158.74 | 13.08 | 6.51 | 138.63 |
| Low | 0.4176 | 152.63 | 13.01 | 6.29 | 135.17 |
| Last | 0.4580 | 158.42 | 13.03 | 6.38 | 135.99 |
| Change | +0.0280 | +5.06 | -0.04 | +0.11 | -1.77 |
| % Change | +6.51% | +3.30% | -0.31% | +1.75% | -1.28% |
| Volume | 796,221 | 5,236,447 | 1,213,474 | 673,400 | 717,500 |
| 20-Day Average Volume | 1,716,205 | 4,280,780 | 1,749,070 | 1,343,420 | 765,780 |
| Previous Close | 0.4300 | 153.36 | 13.07 | 6.27 | 137.76 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5198 | 157.36 | 13.39 | 6.67 | 136.46 |
| 20-Day Raw Stochastic | 11.77% | 55.16% | 3.23% | 21.14% | 39.41% |
| 20-Day Relative Strength | 51.28% | 43.71% | 33.29% | 44.13% | 49.27% |
| Weighted Alpha | +15.84 | -14.57 | -22.33 | -2.54 | +35.60 |
| Today's Opinion | 88% Buy | 72% Sell | 100% Sell | 100% Sell | 48% Buy |
| Previous Opinion | 88% Buy | 88% Sell | 100% Sell | 100% Sell | 96% Buy |
| Last Month's Opinion | 56% Buy | 40% Sell | 72% Sell | 88% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.12% since 04/19/24 | +8.14% since 04/19/24 | -1.59% since 04/19/24 | +1.59% since 04/19/24 | +3.02% since 04/19/24 |
| Low | 0.4130 on 04/24/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 6.12 on 04/25/24 | 131.79 on 04/22/24 |
| High | 0.5080 on 04/22/24 | 158.74 on 04/26/24 | 13.41 on 04/23/24 | 6.66 on 04/23/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +15.29% since 03/26/24 | -4.38% since 03/26/24 | -9.45% since 03/26/24 | -1.54% since 03/26/24 | -3.66% since 03/26/24 |
| Low | 0.3751 on 03/27/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 6.12 on 04/25/24 | 130.13 on 04/19/24 |
| High | 0.9099 on 04/04/24 | 171.14 on 03/28/24 | 14.37 on 03/27/24 | 7.35 on 04/09/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +61.40% since 01/26/24 | -17.28% since 01/26/24 | -10.75% since 01/26/24 | -20.35% since 01/26/24 | -4.33% since 01/26/24 |
| Low | 0.2700 on 02/22/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 0.9099 on 04/04/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +61.69% since 10/26/23 | +0.22% since 10/26/23 | -2.62% since 10/26/23 | -17.25% since 10/26/23 | +26.01% since 10/26/23 |
| Low | 0.2501 on 12/20/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 0.9099 on 04/04/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,730 | 70,140,576 | 41,364,172 | 4,311,001 | 13,708,084 |
| Shares Outstanding, K | 66,813 | 457,359 | 3,164,818 | 687,560 | 99,507 |
| Annual Sales | 910,000 | 8,544,000,000 | 29,803,340,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | -11,510,000 | 2,344,000,000 | 2,345,930,000 | 131,340,000 | 249,700,000 |
| Last Quarter Sales | 200,000 | 2,213,000,000 | 7,556,070,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | -5,590,000 | 525,000,000 | 718,900,000 | 125,920,000 | 147,700,000 |
| 60-Month Beta | 1.71 | 0.85 | 0.53 | 0.56 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 02/14/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 0.09 on 07/27/23 | 1.44 on 02/07/24 |
| Latest Earnings Date | 02/13/24 | 05/02/24 | 05/09/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.36 | 6.78 | 0.00 | 57.43 |